Best Telehealth GLP-1 Providers of 2026
Compare reviewed GLP-1 weight loss providers, billing commitments, and the treatments their links actually offer.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Compare the options first
Full comparison & price terms ↓A short preview in editorial order—not a guarantee of the cheapest total bill. Read the commitment terms before choosing.
$49/mo
Lower listed rate · not necessarily monthly billing
Semaglutide $49/mo or tirzepatide $89/mo with 12-month prepayment; $99/$129 month to month.
From $99/mo
Lower listed rate · not necessarily monthly billing
At the October 21, 2026 check, SkinnyRx advertised first-month prices of $99 for injectable compounded semaglutide or tirzepatide, $149 for semaglutide tablets and $199 for tirzepatide tablets. The ongoing monthly rate was not shown on the homepage. Orders are fully refundable until a provider completes the prescription review. Provider-wide published rate; confirm the exact treatment quote.
From $249/mo
Lower listed rate · not necessarily monthly billing
At the August 26, 2026 price check, Direct Meds listed sublingual semaglutide from $249/month and injections from $297/month. Its public process page says medication, nurse support, shipping, and digital follow-ups are included. A licensed clinician reviews the online intake; confirm treatment, dose, and checkout terms before purchase. Provider-wide published rate; confirm the exact treatment quote.
The Ranking
WellMedr
Compounded GLP-1 care with semaglutide shown at $49/mo or tirzepatide at $89/mo with 12-month prepayment; $99/$129 month to month. Verified affiliate coverage is weight loss only.
Editor’s take: WellMedr is our featured value-led compounded GLP-1 option, not a recommendation for unrelated men's-health or hair-loss treatment. Its public Trustpilot profile displayed 4.6/5 from 1,963 reviews when checked September 27, 2026; customer opinions do not establish clinical effectiveness. Recorded price terms were semaglutide $49/mo or tirzepatide $89/mo with 12-month prepayment; $99/$129 month to month. Compounded medications are not FDA-approved finished drugs. Confirm the exact prescription, pharmacy, dose progression, cancellation terms, and total commitment with the clinician before paying.
Full review →SkinnyRx
Clinician-guided GLP-1 platform with both compounded and brand-name access plus overnight shipping.
Editor’s take: Premium positioning, premium catalog. If you want maximum optionality across GLP-1 modalities, this is the deepest menu on the site. The premium catalog comes at a premium price. If you want maximum optionality across GLP-1 modalities, SkinnyRx is the deepest menu on the site; if you want the lowest cost, look at Trimi or HealthRx.
Full review →Direct Meds
Compounded GLP-1 clinic with transparent pricing and dedicated nurse support.
Editor’s take: Direct Meds is easier to compare than a program that separates its membership fee from medication, provided the public $249 and $297 starting points match the treatment path you are offered. Skip it if you specifically want brand-name GLP-1 access or in-state pickup.
Full review →Shed Rx
GLP-1 clinic offering injections, oral semaglutide, drops, and lozenges plus brand-name Wegovy and Zepbound.
Editor’s take: A reasonable mid-priced pick when delivery flexibility matters. Verify auto-billing terms before signing up given mixed reports. Verify auto-billing terms before signing up given mixed reviews on cancellation. If delivery flexibility is your priority, compare ShedRx against Breeze Meds which also offers sublingual tirzepatide.
Full review →Women-focused telehealth combining compounded GLP-1 weight loss with HRT support.
Editor’s take: A focused women's health pick. If you only want GLP-1, you'll find cheaper; if you want both GLP-1 and HRT in one clinic, this is one of the cleanest options on the list. If you only want GLP-1 without hormonal support, a lower-cost specialist like Trimi or HealthRx will be more cost-effective. If you want both GLP-1 and HRT in one clinic, Gala Health is one of the cleanest options available.
Full review →FuturHealth
GLP-1 weight-loss platform combined with personalised nutrition and fitness coaching.
Editor’s take: Coaching is the differentiator. If you're going to use it, FuturHealth pulls ahead of cheaper, drug-only competitors. If you won't, save the money.
Full review →Flexible, medically guided compounded GLP-1 weight loss with transparent monthly pricing.
Editor’s take: Honest, simple, and focused. No brand-name GLP-1 access is the main trade-off, but for cost-conscious first-time users who just want a guided compounded GLP-1 program without upsells or complexity, that trade-off is rational. Transparent monthly pricing with no hidden fees is a genuine differentiator in a category where pricing opacity is common.
Full review →Refills
Multi-category telehealth platform covering GLP-1, ED, hair loss, and longevity peptides with no membership fees and flat dosage pricing.
Editor’s take: A versatile multi-category platform with a competitive GLP-1 entry price and no dose-tier price increases. The breadth of treatments (GLP-1, ED, hair, longevity) makes it a practical single-provider option, though the FDA warning letter regarding compounded semaglutide advertising is worth noting.
Full review →Found
GLP-1 platform that pairs medication with one-on-one coaching and a broad off-label formulary.
Editor’s take: One of the more coaching-forward GLP-1 telehealth options. Pricing tiers can confuse first-time buyers; verify the cancellation terms before subscribing. Pricing tiers can confuse first-time buyers; verify the cancellation policy before subscribing. If you want the lowest possible cost for compounded GLP-1 without coaching, Trimi or HealthRx will be significantly cheaper.
Full review →Strut Health
Broad-catalog telehealth covering hair, skin, weight loss, and sexual health, with free shipping and follow-ups bundled in.
Editor’s take: An efficient generalist. If you want depth in any one category, you'll find better. If you want breadth and a low management overhead, Strut Health is on the shortlist.
Full review →2026 Price Comparison. Published Price Terms
Compare the lower and higher listed rates, then read the billing conditions. A listed monthly equivalent may require prepayment; visits, medication, membership, or shipping can cost extra.
Recorded price-check dates: 15 June 2026 – 21 October 2026. Per-provider dates below; these are not a guarantee of today's checkout price.
Rates use different billing terms and are not necessarily all-in or month-to-month. Confirm total charges and cancellation terms. Compounded medications are not FDA-approved finished drugs; pharmacy type alone does not establish legality or clinical suitability.
31 providers · Trustpilot scores are customer opinions, not treatment results.
| Provider & billing terms | Lower listed rate | Higher listed rate | Pharmacy | Reviews & price check | Actions |
|---|---|---|---|---|---|
| WellMedrBest Value Rate Semaglutide $49/mo or tirzepatide $89/mo with 12-month prepayment; $99/$129 month to month. | Lower listed rate$49/mo | Higher listed rate$99 – $129/mo | Pharmacy503A | 4.6/5 1,963 reviews 30 August 2026 | Go WellMedrRead full review |
| Strut Health Strut Health prices each treatment as a flat monthly fee that includes the medication, provider review, and free shipping. There is no separate membership charge. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $149/mo | Higher listed rateUp to $399/mo | PharmacyNot disclosed | 3.5/5 777 reviews 15 June 2026 | Go Strut HealthRead full review |
| Enhance.MD Enhance.MD uses transparent flat pricing, the monthly subscription includes provider oversight and the chosen medication. NAD+ wafers and injectables are listed at flat in-cart prices. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $149/mo | Higher listed rateUp to $399/mo | PharmacyNot disclosed | 4.1/5 159 reviews 15 June 2026 | Go Enhance.MDRead full review |
| Embody Transparent monthly pricing that bundles compounded GLP-1 medication, provider oversight, and shipping into a single fee. No separate membership charge, no dose surcharges, and no long-term contracts. Pricing is disclosed upfront before you complete intake. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $149/mo | Higher listed rateUp to $349/mo | PharmacyBrand Rx | 3.8/5 6,332 reviews 15 June 2026 | Go EmbodyRead full review |
| Sprout Health Flat-rate pricing covers the medication and provider visits in one number. Combined GLP-1 + NAD+ stacks are priced as bundles. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $99/mo | Higher listed rateUp to $299/mo | PharmacyNot disclosed | 4.0/5 158 reviews 15 June 2026 | Go Sprout HealthRead full review |
| Bodybuilding Health+ Bundled monthly pricing covers medication and provider oversight. Performance-stack add-ons are billed per protocol. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $96/mo | Higher listed rateUp to $299/mo | PharmacyNot disclosed | Score unavailable 15 June 2026 | Go Bodybuilding Health+Read full review |
| SkinnyRx At the October 21, 2026 check, SkinnyRx advertised first-month prices of $99 for injectable compounded semaglutide or tirzepatide, $149 for semaglutide tablets and $199 for tirzepatide tablets. The ongoing monthly rate was not shown on the homepage. Orders are fully refundable until a provider completes the prescription review. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $99/mo | Higher listed rateUp to $199/mo | PharmacyBrand Rx | 4.8/5 5,335 reviews 21 October 2026 | Go SkinnyRxRead full review |
| Gala Health Combined GLP-1 + HRT plans bundle medication and provider oversight in a single monthly price. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $149/mo | Higher listed rateUp to $399/mo | PharmacyNot disclosed | 4.6/5 3,986 reviews 15 June 2026 | Go Gala HealthRead full review |
| FuturHealth At the October 21, 2026 check, FuturHealth's site listed introductory prices for brand-name medication: Foundayo pill and Wegovy pill as low as $198 for the intro month, and Zepbound KwikPen as low as $395 for the intro month. Ongoing monthly pricing was not published on the page; confirm it at checkout. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $198/mo | Higher listed rateUp to $395/mo | PharmacyBrand Rx | 4.6/5 15,774 reviews 21 October 2026 | Go FuturHealthRead full review |
| SynergyRx Each protocol is priced as a flat monthly fee. Brand-name GLP-1 is offered at clinic-published rates. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $109/mo | Higher listed rateUp to $399/mo | PharmacyBrand Rx | Score unavailable 15 June 2026 | Go SynergyRxRead full review |
| Breeze Meds At the August 26, 2026 price check, BreezeMeds listed weight-loss injections from $199 and NAD+ injections from $169. Its public FAQ covers costs, insurance, delivery, clinicians, and pharmacy providers, but the landing page does not display a detailed medication-by-dose price matrix. Confirm treatment, dose, recurring billing, and any fees before checkout. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $199/mo | Higher listed rateUp to $399/mo | PharmacyBrand Rx | Score unavailable 26 August 2026 | Go Breeze MedsRead full review |
| Shed Rx At the October 21, 2026 check, Shed listed compounded semaglutide from $159/month and compounded tirzepatide as low as $239/month, and states that pricing does not increase with dose. Health coaching, follow-ups and shipping are included. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $159/mo | Higher listed rateUp to $239/mo | PharmacyBrand Rx | 4.7/5 956 reviews 21 October 2026 | Go Shed RxRead full review |
| Direct Meds At the August 26, 2026 price check, Direct Meds listed sublingual semaglutide from $249/month and injections from $297/month. Its public process page says medication, nurse support, shipping, and digital follow-ups are included. A licensed clinician reviews the online intake; confirm treatment, dose, and checkout terms before purchase. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $249/mo | Higher listed rateUp to $297/mo | PharmacyBrand Rx | 4.6/5 14,599 reviews 26 August 2026 | Go Direct MedsRead full review |
| Found At the October 21, 2026 check, Found's CORE plan was $129 every 30 days, or $594 for six months (about $99/month); the PLUS self-pay plan was $199/month. Found's terms state GLP-1 medications are not included in any plan fee; Found works with your insurer on coverage, otherwise medication is paid separately. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $129/mo | Higher listed rateUp to $349/mo | PharmacyBrand Rx | 4.0/5 729 reviews 21 October 2026 | Go FoundRead full review |
| Willow Willow bundles physician oversight, medication, free two-day shipping, and unlimited messaging into one premium monthly fee. There is no brand-name medication option and no insurance billing. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $299/mo | Higher listed rateUp to $549/mo | PharmacyBrand Rx | 3.9/5 359 reviews 15 June 2026 | Go WillowRead full review |
| YourEra YourEra bundles the provider visit, prescription, and compounded GLP-1 medication into a single monthly plan starting at $99. FSA and HSA eligible. No insurance required. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $99/mo | Higher listed rateUp to $299/mo | PharmacyBrand Rx | Score unavailable 15 June 2026 | Go YourEraRead full review |
| FeelGood FeelGood prices start at $149/mo for compounded injections and $249/mo for oral tablets. Brand-name original injections start at $1,999/mo. No membership or hidden fees, everything is included. Free shipping on all orders. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $149/mo | Higher listed rateUp to $349/mo | PharmacyBrand Rx | Score unavailable 15 June 2026 | Go FeelGoodRead full review |
| TrimiLowest Flat Rate Flat rate at every dose. | Lower listed rate$99/mo | Higher listed rate$125/mo | Pharmacy503A | Score unavailable 24 June 2026 | Go TrimiRead full review |
| Cielo Health Cielo charges from $115/mo for compounded semaglutide and from $180/mo for compounded tirzepatide on a 3-month plan. Single-month rates are $199/mo (semaglutide) and $299/mo (tirzepatide). Physician consult and shipping are included at no extra cost. Every batch is third-party tested. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $115/mo | Higher listed rateUp to $299/mo | PharmacyNot disclosed | 4.3/5 10 reviews 24 June 2026 | Go Cielo HealthRead full review |
| Remote Pharmacy Remote Pharmacy charges no subscription or membership fee. Compounded tirzepatide starts at $229/mo (starter dose) and $349/mo (maintenance). Compounded semaglutide pricing is comparable. Physician consult and shipping are included at no extra charge. Same-day approvals available for orders placed before 2 pm ET. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $229/mo | Higher listed rateUp to $349/mo | PharmacyNot disclosed | Score unavailable 24 June 2026 | Go Remote PharmacyRead full review |
| Refills Refills advertises GLP-1 programs from $5/day (approximately $150/mo). No membership or app fees. All dosages are priced the same (no dose-tier price increases). Free shipping. ED medications (sildenafil, tadalafil, Cialis, Viagra), hair loss (finasteride, minoxidil), and longevity peptides (NAD+, sermorelin, methylene blue) are also available. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $150/mo | Higher listed rateUp to $299/mo | PharmacyNot disclosed | 4.0/5 1,425 reviews 24 June 2026 | Go RefillsRead full review |
| AltRx AltRx advertises compounded semaglutide from $89/mo (promotional first-month pricing) with standard pricing from $159/mo. Compounded tirzepatide (GLP-1+GIP) starts at $129/mo promotional or $279/mo standard. Brand-name Zepbound and Mounjaro are available from $1,249/mo. No hidden fees, no insurance required. Buy Now Pay Later options available. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $89/mo | Higher listed rateUp to $279/mo | PharmacyBrand Rx | Score unavailable 24 June 2026 | Go AltRxRead full review |
| Telos Rx Oral tirzepatide from $49/mo; injectable tirzepatide from $139/mo; semaglutide from $99/mo. Price varies by treatment and plan length. | Lower listed rate$49/mo | Higher listed rateUp to $399/mo | Pharmacy503A/503B | 4.9/5 3 reviews 13 July 2026 | Go Telos RxRead full review |
| HealthRx Compounded semaglutide from $99/mo (12-month plan) or $133/mo (3-month plan). Compounded tirzepatide from $149/mo (12-month) or $209/mo (3-month). All plans include provider review, dose adjustments, and free overnight shipping. HSA/FSA eligible. 30-day money-back guarantee if provider does not approve. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $99/mo | Higher listed rateUp to $209/mo | Pharmacy503A | 3.4/5 51 reviews 18 July 2026 | Go HealthRxRead full review |
| CoreAge Rx CoreAge Rx’s landing page lists $99/mo and $149/mo GLP-1 plan figures and states that displayed starting prices are based on a 12-month plan paid in full. Confirm the medication, total prepaid amount, fulfillment, and cancellation terms during enrollment; month-to-month pricing was not published on the reviewed page. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $99/mo | Higher listed rateUp to $149/mo | PharmacyNot disclosed | Score unavailable 15 August 2026 | Go CoreAge RxRead full review |
| Pallas Health Pallas advertises compounded semaglutide at $139 for the first month, then $597 every 12 weeks ($199/mo average), and compounded tirzepatide at $179 for the first month, then $897 every 12 weeks ($299/mo average). Prices include provider care; confirm the renewal charge and medication selection during intake. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $139/mo | Higher listed rateUp to $299/mo | PharmacyBrand Rx | Score unavailable 15 August 2026 | Go Pallas HealthRead full review |
| Zealthy Zealthy advertises FDA-approved GLP-1 options from $25/month when insurance coverage applies and cash-pay semaglutide from $151/month on a three-month purchase. The $25 insurance figure and $151 three-month-plan monthly equivalent are not one universal all-in price; confirm the medication, membership, dose, up-front commitment and out-of-pocket total during intake. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $25/mo | Higher listed rateUp to $151/mo | PharmacyBrand Rx | 3.2/5 6,043 reviews 31 August 2026 | Go ZealthyRead full review |
| SnagRx SnagRx advertises compounded semaglutide from $69/month and compounded tirzepatide from $119/month, with provider review, supplies and shipping described as included. Its page presents the figures as a current discount, so confirm the exact starting price, dose, recurring charge, pharmacy and state availability before enrollment. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $69/mo | Higher listed rateUp to $119/mo | PharmacyNot disclosed | 3.1/5 7 reviews 26 August 2026 | Go SnagRxRead full review |
| MEDGm MEDGm’s public GLP-1 page lists injections from $169/month and tablets from $239/month, with medication included in the compounded-program price. It separately lists membership-plus-medication arrangements for Zepbound, Wegovy and Ozempic, with availability subject to change. Confirm the selected formulation, dose, recurring price, pharmacy, state availability and any payment or cancellation terms before enrolling. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $169/mo | Higher listed rateUp to $239/mo | PharmacyBrand Rx | Score unavailable 6 September 2026 | Go MEDGmRead full review |
| Hume Care Hume Care’s reviewed oral GLP protocol pages show an introductory offer from $199 per month, with automatic refills described. The public pages frame this as an introductory price and do not state a standard non-promotional recurring amount, named active ingredient, or all dose levels. Confirm the prescribed medication, recurring charge after any offer, clinical eligibility, pharmacy, refill schedule and cancellation terms before enrolling. Provider-wide published rate; confirm the exact treatment quote. | Lower listed rateFrom $199/mo | Higher listed rateSee current terms | PharmacyNot disclosed | Score unavailable 10 September 2026 | Go Hume CareRead full review |
| Collective $59–$69/mo is the medication price; $199 annual membership after a 21-day trial is separate. | Lower listed rateFrom $59/mo | Higher listed rateUp to $69/mo | PharmacyNot disclosed | 4.5/5 38 reviews 16 September 2026 | Go CollectiveRead full review |
Provider links may earn a commission. Rate sorting compares the displayed numbers, not equivalent treatment plans or total commitments. How we check price terms →
What to know before choosing
GLP-1 receptor agonists have moved the entire weight-loss conversation, with the STEP 1 trial (NEJM 2021) showing 14.9% mean weight loss for semaglutide and the SURMOUNT-1 trial (NEJM 2022) showing 20.9% mean weight loss with tirzepatide 15 mg at 72 weeks by the treatment-regimen estimand. These were separate trials, not a head-to-head comparison. Telehealth opens access, but pricing, dosing flexibility, and the difference between brand-name and compounded formulations vary widely between providers. We evaluated 57 telehealth providers that prescribe GLP-1s and ranked the ones that combine clinical oversight, formulary breadth, and transparent pricing.
GLP-1 receptor agonists have produced substantial weight loss in separate randomised controlled trials. The STEP 1 trial (NEJM 2021) showed 14.9% mean body-weight reduction with weekly semaglutide 2.4 mg over 68 weeks. The SURMOUNT-1 trial (NEJM 2022) showed 20.9% with tirzepatide 15 mg over 72 weeks. In the separate ATTAIN-1 trial (NEJM 2025), once-daily orforglipron 36 mg produced −11.2% mean body-weight change at 72 weeks by the treatment-regimen estimand (−12.4% by the efficacy estimand). These trials differed in populations, protocols, and duration, so their efficacy figures are not head-to-head comparisons.
Telehealth has made these medications accessible without an in-person visit, but the market is fragmented. Some providers offer only compounded semaglutide, while others carry brand-name Wegovy and Zepbound. Pricing ranges from under $100/month for compounded formulations to over $1,500/month for brand-name injectables without insurance. Clinical oversight quality varies just as widely — from synchronous video visits with licensed physicians to fully asynchronous questionnaire-only consults.
We evaluated 57 telehealth providers that prescribe GLP-1s and ranked the ones that combine formulary breadth, transparent pricing, real clinical oversight, and reliable pharmacy fulfillment. The order below reflects our editorial assessment together with affiliate-offer eligibility, as explained in our methodology.
Methodology
We include providers with GLP-1 category coverage. Display order gives priority to providers with a supplied category-matched affiliate destination, then uses our manually maintained editorial score and available Trustpilot signal; the score reflects our review of formulary, disclosed pricing, clinical oversight, and fulfillment details. Affiliate status is not a clinical-quality measure, and no provider paid for editorial placement.
What You Actually Need to Know Before Starting a Telehealth GLP-1
GLP-1 telehealth has gone from niche-clinic curiosity to mainstream weight-loss infrastructure in less than three years. The marketing has matured faster than the consumer literacy — most patients we hear from sign up not fully understanding the difference between Wegovy and a compounded semaglutide preparation, what a 503B pharmacy is, or how the FDA shortage list quietly determines whether the medication they're taking is even legal next quarter. The notes below are the briefing we'd give a friend before they signed up for any of the providers ranked above.
Compounded vs Brand-Name: The Distinction Most Pages Skip
When you sign up for a 'GLP-1 program' through telehealth, you are usually being prescribed one of two materially different products. The first is FDA-approved Wegovy or Zepbound — manufactured by Novo Nordisk and Eli Lilly respectively, with the same active ingredient and the same labeled dosing as the medication used in pivotal randomized trials. The second is compounded semaglutide or compounded tirzepatide, prepared by a state-licensed compounding pharmacy, not reviewed by the FDA for safety, efficacy, manufacturing quality, or labeling.
Compounded does not mean illegal. Under section 503A of the FD&C Act, traditional compounding pharmacies can prepare a copy of an FDA-approved drug only when that drug appears on the FDA's drug-shortage list. Throughout most of 2023 and 2024, both semaglutide and tirzepatide were on the list — making compounded versions broadly available through telehealth. Once the FDA removes a drug from the shortage list, the legal pathway for compounded copies narrows considerably. This means the compounded GLP-1 you start today may not be available the same way in six months. It is a real risk for a long-term protocol like weight management.
Practically, if you can afford brand-name Wegovy or Zepbound (with or without insurance), or if you have insurance that covers it, that is the cleaner pharmacological choice — same molecule, FDA oversight, predictable supply, predictable formulary. If cost rules out the brand-name pathway, compounded GLP-1s offered by clinics that disclose their pharmacy partner (ideally a 503B outsourcing facility) and provide a clear formulary statement are the next-best option. Clinics that obscure their compounding source or refuse to name a 503A vs 503B partner are an immediate yellow flag.
What the Trial Numbers Actually Mean
Wegovy's pivotal trial (STEP 1) showed a mean weight loss of 14.9% over 68 weeks at the 2.4 mg dose, versus 2.4% on placebo. Zepbound's pivotal trial (SURMOUNT-1) showed 20.9% over 72 weeks at the 15 mg dose, versus 3.1% on placebo. Both figures are remarkable — historically, lifestyle-only weight-loss programs produce 3-6% loss at 12 months, and pre-GLP-1 weight-loss medications produced 5-10%.
Two cautions about reading these numbers: first, both trials excluded participants with diabetes (a separate trial population) and titrated up to the maintenance dose over 16-20 weeks, which means your first three months on therapy will not look like the trial average. Second, the trials measured percent of body weight at week 68 or 72 against baseline — they did not measure five-year sustained loss. Real-world data is still emerging, but rebound after discontinuation is common, which is why most clinicians and our editorial position favor framing GLP-1 therapy as long-term metabolic medicine rather than a short-term weight-loss tool.
What Good Clinical Oversight Looks Like
GLP-1s are not benign drugs. The FDA labels carry warnings for pancreatitis, gallbladder disease, and (in animal models) thyroid C-cell tumors. The most common side effects — nausea, diarrhea, vomiting, constipation — are dose-dependent and usually titration-related, but they are not trivial: a patient titrating too quickly can lose meaningful weight from sheer GI distress, which is not the goal.
A telehealth clinic that does GLP-1 well will: (a) require a structured intake covering personal and family history of pancreatitis, thyroid cancer, and gallbladder disease; (b) titrate the dose on a defined schedule rather than letting the patient self-escalate; (c) make it easy to message a clinician when side effects appear, rather than gating support behind another consult fee; and (d) ask about adjacent medications — particularly for type 1 or insulin-using type 2 diabetics, where GLP-1s can cause hypoglycemia.
- Clinic does a structured medical history before prescribing, not just BMI screening
- Titration is provider-controlled, not patient-controlled
- Asynchronous messaging is unlimited and free, not gated behind extra consult fees
- The pharmacy partner is named (especially for compounded protocols)
- Refills require a brief check-in, not just a credit-card hit
The Real Monthly Cost
Headline pricing on a telehealth GLP-1 page is rarely the all-in monthly cost. Look for these line items: the program/membership fee, the medication fee at your maintenance dose (not your starting dose), shipping, lab work (some clinics require baseline labs), and any add-on charges for nutrition coaching or premium tiers. Compounded plans on flat-rate pricing avoid the dose-tier surprise; brand-name plans pass through the medication's published wholesale cost plus a markup.
For the 35+ providers in our directory, all-in monthly cost at the maintenance dose ranges from roughly $179/month (low-end compounded with no extras) to $1,400+/month (brand-name Wegovy or Zepbound at retail without insurance). The ranking above factors in this all-in cost, not the marketing-headline number.
If you take one thing away from this section: ask the clinic, before signing up, what the all-in monthly cost will be at your maintenance dose, where the medication is dispensed from, and how dose changes are handled. Any provider that hesitates on those three questions is not the right one — regardless of how aggressive the ad copy is.
What the Studies Actually Show
GLP-1 receptor agonists, semaglutide (Wegovy/Ozempic) and tirzepatide (Zepbound/Mounjaro), are the active ingredients prescribed by every provider on this list. The figures below summarise the pivotal Phase 3 trials and the current FDA prescribing information.
| Endpoint | Finding |
|---|---|
| Mean weight loss (STEP 1, 68 weeks, 2.4 mg)1 | −14.9% body weight vs −2.4% placebo in adults with overweight/obesity without diabetes |
| Cardiovascular outcomes (SELECT, ~40 months)2 | 20% relative risk reduction in major adverse cardiovascular events (MACE) in adults with established CV disease and overweight/obesity |
| GI side effects (FDA prescribing information)3 | Nausea ≥10%, diarrhea ≥10%, vomiting ≥10%, constipation ≥10%; most cases mild–moderate and dose-dependent |
| Boxed warning3 | Risk of thyroid C-cell tumors observed in rodent studies; contraindicated in personal/family history of MTC or MEN 2 |
| Mean weight loss (SURMOUNT-1, 72 weeks, 15 mg)6 | −20.9% body weight vs −3.1% placebo in adults with obesity without diabetes |
| Mean weight loss with T2D (SURMOUNT-2, 72 weeks, 15 mg)7 | −14.7% body weight in adults with type 2 diabetes |
| Sleep apnea (SURMOUNT-OSA)8 | Tirzepatide reduced apnea-hypopnea index (AHI) by ~25–29 events/hour vs placebo at 52 weeks; FDA-approved labeling for moderate-to-severe OSA in obesity |
Frequently Asked Questions
What is the difference between compounded and brand-name GLP-1?
Which telehealth providers prescribe brand-name Wegovy and Zepbound?
Within our list, TrimRx, MEDVi, Eden, GetThinMD, SkinnyRx, FuturHealth, JRNYS, PlushCare, and Ro all offer FDA-approved Wegovy and/or Zepbound through licensed clinicians.
Are compounded GLP-1s safe?
Compounded medications are legal when prescribed by a licensed clinician and dispensed by a state-licensed compounding pharmacy. Always verify the pharmacy's licensure and ask whether the active ingredient is sourced from an FDA-registered facility.
- STEP 1 — NEJM 2021 · Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 2021;384:989–1002.
- SELECT — NEJM 2023 · Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med 2023;389:2221–2232.
- SURMOUNT-1 — NEJM 2022 · Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med 2022;387:205–216.
- SURMOUNT-2 — Lancet 2023 · Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 2023;402(10402):613–626.
- SURMOUNT-OSA — NEJM 2024 · Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med 2024;391:1193–1205.
- SURPASS — program summary · Frias JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). N Engl J Med 2021;385:503–515.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.
Comparing Hims, Hers, Ro or Found?
Read our four-provider comparison of published pricing, care models, and the questions to check before enrolling. A comparison is not confirmation that a particular medication is currently available.
Hims vs Hers vs Ro vs FoundCompare Top Providers
- Foundayo vs Zepbound: Evidence and Administration (2026)
- Foundayo vs Wegovy: Evidence and Administration (2026)
- Ozempic vs Wegovy: What Is the Difference in 2026?
- Henry Meds vs Ro: Which Telehealth Platform Wins in 2026?
- Eden vs Henry Meds: Compounded GLP-1 Compared
- Wegovy vs Zepbound: Which Should You Choose?
- FuturHealth vs Found (2026): GLP-1 + Coaching Compared
- Sesame Care vs Found (2026): Pay-Per-Visit vs Subscription GLP-1
- Mochi Health vs Henry Meds (2026): Which GLP-1 Clinic Is Better?